← Back to Clinical Trials
Recruiting NCT06400043

NCT06400043 Dual-tasking Effect on Gait in Children With Developmental Coordination Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06400043
Status Recruiting
Phase
Sponsor University Ghent
Condition Gait
Study Type INTERVENTIONAL
Enrollment 23 participants
Start Date 2024-07-12
Primary Completion 2026-08-31

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Cognitive dual-taskMotor dual-task

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 23 participants in total. It began in 2024-07-12 with a primary completion date of 2026-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to collect data in children with developmental coordination disorder (DCD) aged between 7 and 17 years for analyses of the gait pattern while walking at the Gait Real-time Analysis Interactive Lab (GRAIL) at the university hospital of Ghent. Children with DCD will be asked to take a motor test (M-ABC-2) as well as walk on the treadmill during a single session of approximately 3 hours. The following data will be collected on the GRAIL while subjects walk at different gait speeds: 3D kinematics, kinetics, and EMG. Additionally, 3D kinematics, kinetics, and EMG data will be collected when performing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) dual-task while walking at comfortable walking speed..

Eligibility Criteria

Inclusion Criteria: * They have an official DCD diagnosis; * Are aged between 7 and 17 years old; * Can walk at least 15 minutes consecutively; * Have good or corrected vision. Exclusion Criteria: * They suffer from a neurological disorder; * Take medications that affect gait and balance; * Have undergone surgical procedures on the lower limbs in the past; * Experience pain in their lower limbs or back at the time of testing.

Contact & Investigator

Central Contact

Michelle Verhoeven

✉ michelle.verhoeven@ugent.be

📞 +32 9 332 46 57

Principal Investigator

Lynn Bar-On

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT06400043 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 17 Years, studying Gait. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06400043 currently recruiting?

Yes, NCT06400043 is actively recruiting participants. Contact the research team at michelle.verhoeven@ugent.be for enrollment information.

Where is the NCT06400043 trial being conducted?

This trial is being conducted at Ghent, Belgium, Ghent, Belgium.

Who is sponsoring the NCT06400043 clinical trial?

NCT06400043 is sponsored by University Ghent. The principal investigator is Lynn Bar-On at University Ghent. The trial plans to enroll 23 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology